Advertisement

Anal Cancer

  • Mark Lane Welton
  • Nalini Raju
Chapter

Abstract

This chapter reviews the anatomy that defines anal and ­perianal squamous cell carcinomas (SCC), discusses the cancers and precursor lesions that are most commonly found in these regions, and concludes with brief discussions of the less common malignancies of the anus and perineum.

Keywords

Anal Canal Anal Cancer Wide Local Excision Verrucous Carcinoma Anal Intraepithelial Neoplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jemal A et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.PubMedGoogle Scholar
  2. 2.
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. Springer: New York, NY; 2010.Google Scholar
  3. 3.
    Welton ML, Sharkey FE, Kahlenberg MS. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am. 2004;13(2):263–75.PubMedGoogle Scholar
  4. 4.
    Frisch M et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337(19):1350–8.PubMedGoogle Scholar
  5. 5.
    Munoz N et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.PubMedGoogle Scholar
  6. 6.
    Strickler HD, Schiffman MH. Is human papillomavirus an infectious cause of non-cervical anogenital tract cancers? BMJ. 1997;315(7109):620–1.PubMedGoogle Scholar
  7. 7.
    Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102(5A):3–8.PubMedGoogle Scholar
  8. 8.
    O’Mahony C et al. New patient-applied therapy for anogenital warts is rated favourably by patients. Int J STD AIDS. 2001;12(9):565–70.PubMedGoogle Scholar
  9. 9.
    Bauer HM et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265(4):472–7.PubMedGoogle Scholar
  10. 10.
    Pecoraro G, Morgan D, Defendi V. Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc Natl Acad Sci USA. 1989;86(2):563–7.PubMedGoogle Scholar
  11. 11.
    Woodworth CD, Doniger J, DiPaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol. 1989;63(1):159–64.PubMedGoogle Scholar
  12. 12.
    van der Snoek EM et al. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis. 2003;30(8):639–44.PubMedGoogle Scholar
  13. 13.
    Palefsky JM et al. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA. 1990;263(21):2911–6.PubMedGoogle Scholar
  14. 14.
    Palefsky JM et al. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 1991;51(3):1014–9.PubMedGoogle Scholar
  15. 15.
    Jay N et al. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum. 1997;40(8):919–28.PubMedGoogle Scholar
  16. 16.
    Holly EA et al. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst. 1989;81(22):1726–31.PubMedGoogle Scholar
  17. 17.
    Bosch FX et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65.PubMedGoogle Scholar
  18. 18.
    Hildesheim A et al. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. Cancer Epidemiol Biomarkers Prev. 1997;6(10):807–13.PubMedGoogle Scholar
  19. 19.
    Palefsky JM et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis. 2001;183(3):383–91.PubMedGoogle Scholar
  20. 20.
    Holly EA et al. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst. 2001;93(11):843–9.PubMedGoogle Scholar
  21. 21.
    Sobhani I et al. Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology. 2001;120(4):857–66.PubMedGoogle Scholar
  22. 22.
    Cress RD, Holly EA. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973–1999. Prev Med. 2003;36(5):555–60.PubMedGoogle Scholar
  23. 23.
    Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer. 1986;58(3):611–6.PubMedGoogle Scholar
  24. 24.
    Penn I. Cancer in the immunosuppressed organ recipient. Transplant Proc. 1991;23(2):1771–2.PubMedGoogle Scholar
  25. 25.
    Vajdic CM et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296(23):2823–31.PubMedGoogle Scholar
  26. 26.
    McGlennen RC. Human papillomavirus oncogenesis. Clin Lab Med. 2000;20(2):383–406.PubMedGoogle Scholar
  27. 27.
    zur Hausen H. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol. 1999;9(6):405–11.PubMedGoogle Scholar
  28. 28.
    Martin F, Bower M. Anal intraepithelial neoplasia in HIV positive people. Sex Transm Infect. 2001;77(5):327–31.PubMedGoogle Scholar
  29. 29.
    Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248(4951):76–9.PubMedGoogle Scholar
  30. 30.
    Chow LT, Broker TR. Papillomavirus DNA replication. Intervirology. 1994;37(3–4):150–8.PubMedGoogle Scholar
  31. 31.
    Dollard SC et al. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF. Genes Dev. 1992;6(7):1131–42.PubMedGoogle Scholar
  32. 32.
    Flores ER, Lambert PF. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol. 1997;71(10):7167–79.PubMedGoogle Scholar
  33. 33.
    Litle VR et al. Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesions. Dis Colon Rectum. 2000;43(3):346–52.PubMedGoogle Scholar
  34. 34.
    Chang GJ et al. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum. 2002;45(4):453–8.PubMedGoogle Scholar
  35. 35.
    Pineda CE et al. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum. 2008;51(6):829–35. discussion 835–7.PubMedGoogle Scholar
  36. 36.
    Goldie SJ et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999;281(19):1822–9.PubMedGoogle Scholar
  37. 37.
    Goldie SJ et al. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med. 2000;108(8):634–41.PubMedGoogle Scholar
  38. 38.
    Daling JR et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317(16):973–7.PubMedGoogle Scholar
  39. 39.
    Scholefield JH et al. Anal and cervical intraepithelial neoplasia: possible parallel. Lancet. 1989;2(8666):765–9.PubMedGoogle Scholar
  40. 40.
    Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst. 1994;86(22):1711–6.PubMedGoogle Scholar
  41. 41.
    Koblin BA et al. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978–1990. Am J Epidemiol. 1996;144(10):916–23.PubMedGoogle Scholar
  42. 42.
    Critchlow CW et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS. 1995;9(11):1255–62.PubMedGoogle Scholar
  43. 43.
    Palefsky JM et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17(4):320–6.PubMedGoogle Scholar
  44. 44.
    Palefsky JM et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17(4):314–9.PubMedGoogle Scholar
  45. 45.
    Chaturvedi AK et al. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101(16):1120–30.PubMedGoogle Scholar
  46. 46.
    Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92(18):1500–10.PubMedGoogle Scholar
  47. 47.
    Jemal A et al. Cancer statistics, 2003. CA Cancer J Clin. 2003;53(1):5–26.PubMedGoogle Scholar
  48. 48.
    Goldman S et al. Incidence of anal epidermoid carcinoma in Sweden 1970–1984. Acta Chir Scand. 1989;155(3):191–7.PubMedGoogle Scholar
  49. 49.
    Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ. 1993;306(6875):419–22.PubMedGoogle Scholar
  50. 50.
    Ciobotaru B et al. Prevalence and risk factors for anal cytologic abnormalities and human papillomavirus infection in a rural population of HIV-infected males. Dis Colon Rectum. 2007;50(7):1011–6.PubMedGoogle Scholar
  51. 51.
    Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet. 1991;338(8768):657–9.PubMedGoogle Scholar
  52. 52.
    Holmes F et al. Anal cancer in women. Gastroenterology. 1988;95(1):107–11.PubMedGoogle Scholar
  53. 53.
    Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr. 1994;7(6):599–606.PubMedGoogle Scholar
  54. 54.
    Caussy D et al. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men. Int J Cancer. 1990;46(2):214–9.PubMedGoogle Scholar
  55. 55.
    Friedman HB et al. Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. J Infect Dis. 1998;178(1):45–52.PubMedGoogle Scholar
  56. 56.
    Palefsky JM et al. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS. 1998;12(5):495–503.PubMedGoogle Scholar
  57. 57.
    Ogunbiyi OA et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg. 1994;81(3):365–7.PubMedGoogle Scholar
  58. 58.
    Daling JR et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992;135(2):180–9.PubMedGoogle Scholar
  59. 59.
    Marfing TE, Abel ME, Gallagher DM. Perianal Bowen’s disease and associated malignancies. Results of a survey. Dis Colon Rectum. 1987;30(10):782–5.PubMedGoogle Scholar
  60. 60.
    Arbesman H, Ransohoff DF. Is Bowen’s disease a predictor for the development of internal malignancy? A methodological critique of the literature. JAMA. 1987;257(4):516–8.PubMedGoogle Scholar
  61. 61.
    Margenthaler JA et al. Outcomes, risk of other malignancies, and need for formal mapping procedures in patients with perianal Bowen’s disease. Dis Colon Rectum. 2004;47(10):1655–60. discussion 1660–1.PubMedGoogle Scholar
  62. 62.
    Marchesa P et al. Perianal Bowen’s disease: a clinicopathologic study of 47 patients. Dis Colon Rectum. 1997;40(11):1286–93.PubMedGoogle Scholar
  63. 63.
    Brown SR et al. Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen’s disease). Br J Surg. 1999;86(8):1063–6.PubMedGoogle Scholar
  64. 64.
    Bargman H, Hochman J. Topical treatment of Bowen’s disease with 5-Fluorouracil. J Cutan Med Surg. 2003;7(2):101–5.PubMedGoogle Scholar
  65. 65.
    Graham BD et al. Topical 5-fluorouracil in the management of extensive anal Bowen’s disease: a preferred approach. Dis Colon Rectum. 2005;48(3):444–50.PubMedGoogle Scholar
  66. 66.
    Wang KH et al. Erbium:YAG laser pretreatment accelerates the response of Bowen’s disease treated by topical 5-fluorouracil. Dermatol Surg. 2004;30(3):441–5.PubMedGoogle Scholar
  67. 67.
    Snoeck R et al. Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome. Arch Intern Med. 2001;161(19):2382–4.PubMedGoogle Scholar
  68. 68.
    Okamoto A et al. Combination therapy with podophyllin and vidarabine for human papillomavirus positive cervical intraepithelial neoplasia. Oncol Rep. 1999;6(2):269–76.PubMedGoogle Scholar
  69. 69.
    Micali G, Nasca MR, Tedeschi A. Topical treatment of intraepithelial penile carcinoma with imiquimod. Clin Exp Dermatol. 2003;28 Suppl 1:4–6.PubMedGoogle Scholar
  70. 70.
    Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen’s disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg. 2001;27(6):561–4.PubMedGoogle Scholar
  71. 71.
    Pehoushek J, Smith KJ. Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man. Arch Dermatol. 2001;137(1):14–6.PubMedGoogle Scholar
  72. 72.
    Panizzon RG. Radiotherapy of skin tumors. Recent Results Cancer Res. 2002;160:234–9.PubMedGoogle Scholar
  73. 73.
    Chung YL et al. Treatment of Bowen’s disease with a specially designed radioactive skin patch. Eur J Nucl Med. 2000;27(7):842–6.PubMedGoogle Scholar
  74. 74.
    Webber J, Fromm D. Photodynamic therapy for carcinoma in situ of the anus. Arch Surg. 2004;139(3):259–61.PubMedGoogle Scholar
  75. 75.
    Varma S et al. Bowen’s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144(3):567–74.PubMedGoogle Scholar
  76. 76.
    Salim A et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen’s disease. Br J Dermatol. 2003;148(3):539–43.PubMedGoogle Scholar
  77. 77.
    Behrendt GC, Hansmann ML. Carcinomas of the anal canal and anal margin differ in their expression of cadherin, cytokeratins and p53. Virchows Arch. 2001;439(6):782–6.PubMedGoogle Scholar
  78. 78.
    Gervasoni Jr JE, Wanebo HJ. Cancers of the anal canal and anal margin. Cancer Invest. 2003;21(3):452–64.PubMedGoogle Scholar
  79. 79.
    Skibber J, Rodriguez-Bigas MA, Gordon PH. Surgical considerations in anal cancer. Surg Oncol Clin N Am. 2004;13(2):321–38.PubMedGoogle Scholar
  80. 80.
    Newlin HE et al. Squamous cell carcinoma of the anal margin. J Surg Oncol. 2004;86(2):55–62. discussion 63.PubMedGoogle Scholar
  81. 81.
    Jensen SL et al. Does an erroneous diagnosis of squamous-cell carcinoma of the anal canal and anal margin at first physician visit influence prognosis? Dis Colon Rectum. 1987;30(5):345–51.PubMedGoogle Scholar
  82. 82.
    Winburn GB. Anal carcinoma or “just hemorrhoids”? Am Surg. 2001;67(11):1048–58.PubMedGoogle Scholar
  83. 83.
    Mendenhall WM et al. Squamous cell carcinoma of the anal margin treated with radiotherapy. Surg Oncol. 1996;5(1):29–35.PubMedGoogle Scholar
  84. 84.
    Papillon J, Chassard JL. Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Series of 57 patients. Dis Colon Rectum. 1992;35(5):422–9.PubMedGoogle Scholar
  85. 85.
    Nivatvongs S. Perianal and anal canal neoplasms. In: Gordon PH, Nivatvongs S, editors. Prinicples and practice of surgery for the colon, rectum, and anus. St. Louis: Quality Medical Publishing; 1999. p. 448–71.Google Scholar
  86. 86.
    Jensen SL et al. Long-term prognosis after radical treatment for squamous-cell carcinoma of the anal canal and anal margin. Dis Colon Rectum. 1988;31(4):273–8.PubMedGoogle Scholar
  87. 87.
    Greenall MJ et al. Epidermoid cancer of the anal margin. Pathologic features, treatment, and clinical results. Am J Surg. 1985;149(1):95–101.PubMedGoogle Scholar
  88. 88.
    Al-Jurf AS, Turnbull RP, Fazio VW. Local treatment of squamous cell carcinoma of the anus. Surg Gynecol Obstet. 1979;148(4):576–8.PubMedGoogle Scholar
  89. 89.
    Schraut WH et al. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer. 1983;51(7):1291–6.PubMedGoogle Scholar
  90. 90.
    Pintor MP, Northover JM, Nicholls RJ. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg. 1989;76(8):806–10.PubMedGoogle Scholar
  91. 91.
    Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg. 1976;184(4):422–8.PubMedGoogle Scholar
  92. 92.
    Peiffert D et al. Conservative treatment by irradiation of epidermoid carcinomas of the anal margin. Int J Radiat Oncol Biol Phys. 1997;39(1):57–66.PubMedGoogle Scholar
  93. 93.
    Touboul E et al. Epidermoid carcinoma of the anal margin: 17 cases treated with curative-intent radiation therapy. Radiother Oncol. 1995;34(3):195–202.PubMedGoogle Scholar
  94. 94.
    Mendenhall WM et al. Squamous cell carcinoma of the anal margin. Oncology (Huntingt). 1996;10(12):1843–8. discussion 1848, 1853–4.Google Scholar
  95. 95.
    Cummings BJ et al. Treatment of perianal carcinoma by radiation(RT) or radiation plus chemotherapy(RTCT). Int J Radiat Oncol Biol Phys. 1986;12:170.Google Scholar
  96. 96.
    Cutuli B et al. Anal margin carcinoma: 21 cases treated at the Institut Curie by exclusive conservative radiotherapy. Radiother Oncol. 1988;11(1):1–6.PubMedGoogle Scholar
  97. 97.
    John MJ et al. Feasibility of non-surgical definitive management of anal canal carcinoma. Int J Radiat Oncol Biol Phys. 1987;13(3):299–303.PubMedGoogle Scholar
  98. 98.
    Roelofsen F, Bartelink H. Combined modality treatment of anal carcinoma. Oncologist. 1998;3(6):413–8.PubMedGoogle Scholar
  99. 99.
    Allal AS et al. The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer. 1997;79(12):2329–35.PubMedGoogle Scholar
  100. 100.
    Bartelink H et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15(5):2040–9.PubMedGoogle Scholar
  101. 101.
    UKCCCR. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet. 1996;348(9034):1049–54.Google Scholar
  102. 102.
    Bieri S, Allal AS, Kurtz JM. Sphincter-conserving treatment of carcinomas of the anal margin. Acta Oncol. 2001;40(1):29–33.PubMedGoogle Scholar
  103. 103.
    Dougherty BG, Evans HL. Carcinoma of the anal canal: a study of 79 cases. Am J Clin Pathol. 1985;83(2):159–64.PubMedGoogle Scholar
  104. 104.
    Rousseau Jr DL, Petrelli NJ, Kahlenberg MS. Overview of anal cancer for the surgeon. Surg Oncol Clin N Am. 2004;13(2):249–62.PubMedGoogle Scholar
  105. 105.
    Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol. 2004;5(3):149–57.PubMedGoogle Scholar
  106. 106.
    Boman BM et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer. 1984;54(1):114–25.PubMedGoogle Scholar
  107. 107.
    Roseau G et al. Endoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal. Gastrointest Endosc. 1994;40(4):447–50.PubMedGoogle Scholar
  108. 108.
    Drudi FM et al. TRUS staging and follow-up in patients with anal canal cancer. Radiol Med (Torino). 2003;106(4):329–37.Google Scholar
  109. 109.
    Giovannini M et al. Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study. Endoscopy. 2001;33(3):231–6.PubMedGoogle Scholar
  110. 110.
    Goldman S et al. Transanorectal ultrasonography in anal carcinoma. A prospective study of 21 patients. Acta Radiol. 1988;29(3):337–41.PubMedGoogle Scholar
  111. 111.
    Christensen AF et al. Three-dimensional anal endosonography may improve staging of anal cancer compared with two-dimensional endosonography. Dis Colon Rectum. 2004;47(3):341–5.PubMedGoogle Scholar
  112. 112.
    Fuchshuber PR et al. Anal canal and perianal epidermoid cancers. J Am Coll Surg. 1997;185(5):494–505.PubMedGoogle Scholar
  113. 113.
    Perera D et al. Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin. Dis Colon Rectum. 2003;46(8):1027–9. discussion 1030–1.PubMedGoogle Scholar
  114. 114.
    Hoffman R et al. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1999;44(1):127–31.PubMedGoogle Scholar
  115. 115.
    Eng C, Abbruzzese J, Minsky BD. Chemotherapy and radiation of anal canal cancer: the first approach. Surg Oncol Clin N Am. 2004;13(2):309–20. viii.PubMedGoogle Scholar
  116. 116.
    Deniaud-Alexandre E et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys. 2003;56(5):1259–73.PubMedGoogle Scholar
  117. 117.
    Touboul E et al. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer. 1994;73(6):1569–79.PubMedGoogle Scholar
  118. 118.
    Gerard JP et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer. 2001;92(1):77–84.PubMedGoogle Scholar
  119. 119.
    Cummings BJ. Treatment of primary epidermoid carcinoma of the anal canal. Int J Colorectal Dis. 1987;2(2):107–12.PubMedGoogle Scholar
  120. 120.
    Wade DS et al. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg Gynecol Obstet. 1989;169(3):238–42.PubMedGoogle Scholar
  121. 121.
    Ryan DP, Mayer RJ. Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol. 2000;12(4):345–52.PubMedGoogle Scholar
  122. 122.
    Hughes LL et al. Radiotherapy for anal cancer: experience from 1979–1987. Int J Radiat Oncol Biol Phys. 1989;17(6):1153–60.PubMedGoogle Scholar
  123. 123.
    Constantinou EC et al. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys. 1997;39(3):651–7.PubMedGoogle Scholar
  124. 124.
    John M et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am. 1996;2(4):205.PubMedGoogle Scholar
  125. 125.
    Myerson RJ et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol. 2001;61(1):15–22.PubMedGoogle Scholar
  126. 126.
    Cummings BJ et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys. 1991;21(5):1115–25.PubMedGoogle Scholar
  127. 127.
    Allal AS et al. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys. 1997;39(5):1099–105.PubMedGoogle Scholar
  128. 128.
    Nguyen WD, Mitchell KM, Beck DE. Risk factors associated with requiring a stoma for the management of anal cancer. Dis Colon Rectum. 2004;47(6):843–6.PubMedGoogle Scholar
  129. 129.
    Ng Ying Kin NY et al. Our experience of conservative treatment of anal canal carcinoma combining external irradiation and interstitial implant: 32 cases treated between 1973 and 1982. Int J Radiat Oncol Biol Phys. 1988;14(2):253–9.PubMedGoogle Scholar
  130. 130.
    Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum. 1987;30(5):324–33.PubMedGoogle Scholar
  131. 131.
    Mitchell SE et al. Squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2001;49(4):1007–13.PubMedGoogle Scholar
  132. 132.
    Nigro ND, Vaitkevicius VK, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17(3):354–6.PubMedGoogle Scholar
  133. 133.
    Buroker TR et al. Combined therapy for cancer of the anal canal: a follow-up report. Dis Colon Rectum. 1977;20(8):677–8.PubMedGoogle Scholar
  134. 134.
    Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum. 1984;27(12):763–6.PubMedGoogle Scholar
  135. 135.
    Flam M et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14(9):2527–39.PubMedGoogle Scholar
  136. 136.
    Hung A et al. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index. Cancer. 2003;97(5):1195–202.PubMedGoogle Scholar
  137. 137.
    Gerard JP et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. ­Long-term results in 95 patients. Radiother Oncol. 1998;46(3):249–56.PubMedGoogle Scholar
  138. 138.
    Lund JA et al. Endoanal ultrasound is of little value in follow-up of anal carcinomas. Dis Colon Rectum. 2004;47(6):839–42.PubMedGoogle Scholar
  139. 139.
    van der Wal BC et al. Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy. J Gastrointest Surg. 2001;5(4):383–7.PubMedGoogle Scholar
  140. 140.
    Zelnick RS et al. Results of abdominoperineal resections for failures after combination chemotherapy and radiation therapy for anal canal cancers. Dis Colon Rectum. 1992;35(6):574–7. discussion 577–8.PubMedGoogle Scholar
  141. 141.
    Pocard M et al. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum. 1998;41(12):1488–93.PubMedGoogle Scholar
  142. 142.
    Ellenhorn JD, Enker WE, Quan SH. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus. Ann Surg Oncol. 1994;1(2):105–10.PubMedGoogle Scholar
  143. 143.
    Allal AS et al. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer. 1999;86(3):405–9.PubMedGoogle Scholar
  144. 144.
    Akbari RP et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum. 2004;47(7):1136–44.PubMedGoogle Scholar
  145. 145.
    Nilsson PJ et al. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg. 2002;89(11):1425–9.PubMedGoogle Scholar
  146. 146.
    Greenall MJ et al. Recurrent epidermoid cancer of the anus. Cancer. 1986;57(7):1437–41.PubMedGoogle Scholar
  147. 147.
    Klas JV et al. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer. 1999;85(8):1686–93.PubMedGoogle Scholar
  148. 148.
    Beal KP et al. Primary adenocarcinoma of the anus treated with combined modality therapy. Dis Colon Rectum. 2003;46(10):1320–4.PubMedGoogle Scholar
  149. 149.
    Basik M et al. Prognosis and recurrence patterns of anal ­adenocarcinoma. Am J Surg. 1995;169(2):233–7.PubMedGoogle Scholar
  150. 150.
    Papagikos M et al. Chemoradiation for adenocarcinoma of the anus. Int J Radiat Oncol Biol Phys. 2003;55(3):669–78.PubMedGoogle Scholar
  151. 151.
    Belkacemi Y et al. Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2003;56(5):1274–83.PubMedGoogle Scholar
  152. 152.
    Malik A, Hull TL, Floruta C. What is the best surgical treatment for anorectal melanoma? Int J Colorectal Dis. 2004;19(2):121–3.PubMedGoogle Scholar
  153. 153.
    Billingsley KG et al. Uncommon anal neoplasms. Surg Oncol Clin N Am. 2004;13(2):375–88.PubMedGoogle Scholar
  154. 154.
    Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84, 836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664–78.PubMedGoogle Scholar
  155. 155.
    Brady MS, Kavolius JP, Quan SH. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum. 1995;38(2):146–51.PubMedGoogle Scholar
  156. 156.
    Thibault C et al. Anorectal melanoma – an incurable disease? Dis Colon Rectum. 1997;40(6):661–8.PubMedGoogle Scholar
  157. 157.
    Weyandt GH et al. Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer. 2003;89(11):2019–22.PubMedGoogle Scholar
  158. 158.
    Bullard KM et al. Surgical therapy for anorectal melanoma. J Am Coll Surg. 2003;196(2):206–11.PubMedGoogle Scholar
  159. 159.
    Moozar KL, Wong CS, Couture J. Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both. Can J Surg. 2003;46(5):345–9.PubMedGoogle Scholar
  160. 160.
    Roumen RM. Anorectal melanoma in The Netherlands: a report of 63 patients. Eur J Surg Oncol. 1996;22(6):598–601.PubMedGoogle Scholar
  161. 161.
    Eton O et al. Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J Clin Oncol. 2002;20(8):2045–52.PubMedGoogle Scholar
  162. 162.
    Tan GY et al. Gastrointestinal stromal tumor of the anus. Tech Coloproctol. 2003;7(3):169–72.PubMedGoogle Scholar
  163. 163.
    Miettinen M et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol. 2001;25(9):1121–33.PubMedGoogle Scholar
  164. 164.
    Walsh TH, Mann CV. Smooth muscle neoplasms of the rectum and anal canal. Br J Surg. 1984;71(8):597–9.PubMedGoogle Scholar
  165. 165.
    Bernick PE et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47(2):163–9.PubMedGoogle Scholar
  166. 166.
    Gibson GE, Ahmed I. Perianal and genital basal cell carcinoma: a clinicopathologic review of 51 cases. J Am Acad Dermatol. 2001;45(1):68–71.PubMedGoogle Scholar
  167. 167.
    Nielsen OV, Jensen SL. Basal cell carcinoma of the anus – a clinical study of 34 cases. Br J Surg. 1981;68(12):856–7.PubMedGoogle Scholar
  168. 168.
    Espana A et al. Perianal basal cell carcinoma. Clin Exp Dermatol. 1992;17(5):360–2.PubMedGoogle Scholar
  169. 169.
    Paterson CA, Young-Fadok TM, Dozois RR. Basal cell carcinoma of the perianal region: 20-year experience. Dis Colon Rectum. 1999;42(9):1200–2.PubMedGoogle Scholar
  170. 170.
    Paget J. On disease of the mammary areola preceding cancer of the mammary gland. St Barth Hosp Rep. 1874;10:87–9.Google Scholar
  171. 171.
    Darier J, Couillaud P. Sur un cas de maladie de Pager de la region kerineo-anal er scrotale. Ann Dermatole dr Syph. 1893;4:25–31.Google Scholar
  172. 172.
    McCarter MD et al. Long-term outcome of perianal Paget’s disease. Dis Colon Rectum. 2003;46(5):612–6.PubMedGoogle Scholar
  173. 173.
    Beck D. Paget’s disease and Bowen’s disease of the anus. Semin Colon Rectal Surg. 1995;6:143–9.Google Scholar
  174. 174.
    Berardi RS, Lee S, Chen HP. Perianal extramammary Paget’s disease. Surg Gynecol Obstet. 1988;167(4):359–66.PubMedGoogle Scholar
  175. 175.
    Tulchinsky H et al. Extramammary Paget’s disease of the perianal region. Colorectal Dis. 2004;6(3):206–9.PubMedGoogle Scholar
  176. 176.
    Jensen SL et al. Paget’s disease of the anal margin. Br J Surg. 1988;75(11):1089–92.PubMedGoogle Scholar
  177. 177.
    Sarmiento JM et al. Paget’s disease of the perianal region – an aggressive disease? Dis Colon Rectum. 1997;40(10):1187–94.PubMedGoogle Scholar
  178. 178.
    Beck DE, Fazio VW. Perianal Paget’s disease. Dis Colon Rectum. 1987;30(4):263–6.PubMedGoogle Scholar
  179. 179.
    Besa P et al. Extramammary Paget’s disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys. 1992;24(1):73–8.PubMedGoogle Scholar
  180. 180.
    Marchesa P et al. Long-term outcome of patients with perianal Paget’s disease. Ann Surg Oncol. 1997;4(6):475–80.PubMedGoogle Scholar
  181. 181.
    Grussendorf-Conen EI. Anogenital premalignant and malignant tumors (including Buschke-Lowenstein tumors). Clin Dermatol. 1997;15(3):377–88.PubMedGoogle Scholar
  182. 182.
    Trombetta LJ, Place RJ. Giant condyloma acuminatum of the anorectum: trends in epidemiology and management: report of a case and review of the literature. Dis Colon Rectum. 2001;44(12):1878–86.PubMedGoogle Scholar
  183. 183.
    Chu QD et al. Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum. 1994;37(9):950–7.PubMedGoogle Scholar
  184. 184.
    Frisch M et al. Cancer in a population-based cohort of men and women in registered homosexual partnerships. Am J Epidemiol. 2003;157(11):966–72.PubMedGoogle Scholar
  185. 185.
    Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Huntingt). 2002;16(4):441–51. 456, 459.Google Scholar
  186. 186.
    Yuhan R et al. Anorectal disease in HIV-infected patients. Dis Colon Rectum. 1998;41(11):1367–70.PubMedGoogle Scholar
  187. 187.
    Place RJ, Huber PJ, Simmang CL. Anorectal lymphoma and AIDS: an outcome analysis. J Surg Oncol. 2000;73(1):1–4. discussion 4–5.PubMedGoogle Scholar
  188. 188.
    Smith 2nd DL, Cataldo PA. Perianal lymphoma in a ­heterosexual and nonimmunocompromised patient: report of a case and review of the literature. Dis Colon Rectum. 1999;42(7):952–4.PubMedGoogle Scholar
  189. 189.
    Flam MS et al. Definitive combined modality therapy of carcinoma of the anus. A report of 30 cases including results of salvage therapy in patients with residual disease. Dis Colon Rectum. 1987;30(7):495–502.PubMedGoogle Scholar
  190. 190.
    Nigro ND. Multidisciplinary management of cancer of the anus. World J Surg. 1987;11(4):446–51.PubMedGoogle Scholar
  191. 191.
    Habr-Gama A et al. Epidermoid carcinoma of the anal canal. Results of treatment by combined chemotherapy and radiation therapy. Dis Colon Rectum. 1989;32(9):773–7.PubMedGoogle Scholar
  192. 192.
    Sischy B et al. Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst. 1989;81(11):850–6.PubMedGoogle Scholar
  193. 193.
    Cho CC et al. Squamous-cell carcinoma of the anal canal: management with combined chemo-radiation therapy. Dis Colon Rectum. 1991;34(8):675–8.PubMedGoogle Scholar
  194. 194.
    Lopez MJ et al. Squamous cell carcinoma of the anal canal. Am J Surg. 1991;162(6):580–4.PubMedGoogle Scholar
  195. 195.
    Doci R et al. Combined chemoradiation therapy for anal cancer. A report of 56 cases. Ann Surg. 1992;215(2):150–6.PubMedGoogle Scholar
  196. 196.
    Johnson D et al. Carcinoma of the anus treated with primary radiation therapy and chemotherapy. Surg Gynecol Obstet. 1993;177(4):329–34.PubMedGoogle Scholar
  197. 197.
    Tanum G, Tveit KM, Karlsen KO. Chemoradiotherapy of anal carcinoma: tumour response and acute toxicity. Oncology. 1993;50(1):14–7.PubMedGoogle Scholar
  198. 198.
    Beck DE, Karulf RE. Combination therapy for epidermoid carcinoma of the anal canal. Dis Colon Rectum. 1994;37(11):1118–25.PubMedGoogle Scholar
  199. 199.
    Smith DE et al. Cancer of the anal canal: treatment with chemotherapy and low-dose radiation therapy. Radiology. 1994;191(2):569–72.PubMedGoogle Scholar
  200. 200.
    Ajani JA et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299(16):1914–21.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Mark Lane Welton
    • 1
  • Nalini Raju
    • 2
  1. 1.Division of General Surgery, Section of Colon and Rectal SurgeryStanford University School of MedicineStanfordUSA
  2. 2.General Surgery, Section of Colon and Rectal SurgeryStanford University School of MedicalStanfordUSA

Personalised recommendations